ProRelix Research
FEBRUARY 12, 2023
Historical events such as the sulfanilamide elixir tragedy that resulted in the mass poisoning and the deaths of hundreds of patients in the 1930s and the thalidomide scandal which caused […] The post Clinical Trial Regulations in the United States appeared first on ProRelix Research.
Drug Channels
FEBRUARY 17, 2023
Today’s guest post comes from Jim Longley, Head of Commercial, Pharma Manufacturer Solutions at GoodRx. Jim discusses GoodRx Assist , a point-of-sale (POS) rebate program designed to help cash-paying patients start and stay on brand-name medication. Click here to learn more about GoodRx Assist. Read on for Jim’s insights. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. d/b/a Drug Channels Institute.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Antidote
FEBRUARY 13, 2023
When matching individuals to medical research opportunities, patient centricity is at the heart of the process for Antidote. Through our best-in-class clinical trial matching software, we provide a streamlined, user-friendly experience for any individual searching for a trial — and now, through our curated journeys, we’re able to refine this process even more.
NIOSH Science Blog: Drugs
FEBRUARY 15, 2023
Why Do Psychosocial Factors of Work Matter? The construction industry has considerable safety and health hazards that result in high rates of injury, illness, and fatality. Common hazards include noise, fall, electrical, and chemical hazards. Approximately 60% of all construction fatalities each year can be attributed to the ‘focus four’ hazards of falls, struck-by, caught in and between, and electrocutions.1 Construction occupational safety and health (OSH) has traditionally focused on eliminat
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Labcorp Drug Development
FEBRUARY 17, 2023
In December 2022, Labcorp and Biomakers signed an agreement that will positively impact thousands of cancer patients in Latin America through greater access to diagnostic molecular profiling and participation in clinical trials. We recently asked Nicolas Kirchuk (NK), CEO and co-founder of Biomakers, and Isagani Chico (IC), MD, VP, global … The post Innovative collaboration between Biomakers and Labcorp to provide greater access to oncology patients in Latin America appeared first on Insig
Drug Discovery Digest brings together the best content for drug research and development professionals from the widest variety of industry thought leaders.
keypoint
FEBRUARY 17, 2023
On April 11, we celebrated the 2022 recipients of the Michelson Philanthropies & Science Prize for Immunology in this live ePanel event. This international prize focuses on transformative research in human immunology, with trans-disease applications to accelerate vaccine and immunotherapeutic discovery. The prize is intended to encourage and support young investigators from a wide range of disciplines and is awarded annually based on work done in the past three years.
Drug Patent Watch
FEBRUARY 17, 2023
This chart shows the drugs with the most patents in France. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.… The post Which pharmaceutical drugs have the most drug patents in France? appeared first on DrugPatentWatch - Make Better Decisions.
Antidote
FEBRUARY 17, 2023
The Summit for Clinical Ops Executives ( known as SCOPE ), is one of the year’s largest conferences focused on clinical research — and one the Antidote team was thrilled to attend in 2023.
Crown Bioscience
FEBRUARY 16, 2023
Next-generation discovery proteomics in preclinical and translational research is an exciting application of this proteomic approach. By leveraging advanced technologies, the ability to identify and quantify thousands of proteins in an unbiased manner can have a significant impact on the overall development of novel therapies.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
EG Life Sciences
FEBRUARY 15, 2023
The year 2022 reflected a transformative path for the drug development industry. It is without a doubt that 2022 predicted change and opportunity in biopharma and biotech clinical trials in 2023. Every year, the FDA’s Center for Drug Evaluation and Research (CDER) clarifies to drug developers required study design elements, as well as other data needed on the drug application to support a full and comprehensive assessment.
Drug Patent Watch
FEBRUARY 16, 2023
This chart shows the pharmaceutical companies with the most patents in Luxembourg. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is… The post Which pharmaceutical companies have the most drug patents in Luxembourg? appeared first on DrugPatentWatch - Make Better Decisions.
Advarra
FEBRUARY 15, 2023
Metrics in general are one of the ways we can gauge how well a program or service delivers. In the world of institutional review boards (IRBs), some measurements can be easily ascertained, such as review turnaround times and submission volumes, which help the human research protection program (HRPP) assess the IRB’s activities. Measurements such as review timelines and volumes are typically easy to obtain and can inform the speed at which the IRB assesses proposed research and provides a determi
Cytel
FEBRUARY 14, 2023
The U.S. FDA has recently provided specific guidance [i] on the design and conduct of trials incorporating an external control group, sometimes known as a synthetic control arm. Their guidance represents the culmination of several other topics related to these trial designs and research themes, such as existing guidance on the use real-world data and real-world evidence, [ii] the use of electronic health records and medical claims to support regulatory decision-making, [iii] and guidance on demo
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
sptlabtech
FEBRUARY 13, 2023
SLAS San Diego 2023 has come and gone, and SPT Labtech were thrilled to be exhibiting at this premier event for life sciences and laboratory automation. This year's conference was bigger and better than ever, bringing together leading experts, innovators, and decision-makers from the industry to share insights, showcase new technologies, and network with one another.
Drug Patent Watch
FEBRUARY 16, 2023
Annual Drug Patent Expirations for AUSTEDO Austedo is a drug marketed by Teva Branded Pharm and is included in one NDA. It is available from one supplier. There are nine… The post New patent for Teva Branded drug AUSTEDO appeared first on DrugPatentWatch - Make Better Decisions.
The Strateos Blog: Drug Discovery
FEBRUARY 13, 2023
Are you interested in discovering how AI and automation can be put to work in the drug discovery space? Then join us at the first SLAS conference of the year in beautiful San Diego, CA, from February 25th – March 1st. It's an event not to be missed! A meeting of the minds, leading industry professionals, including Benchling, GlaxoSmithKline and Strateos, will come together to discuss the technologies, laboratory automation and deep learning tools that are enabling innovative and life
NIOSH Science Blog: Drugs
FEBRUARY 16, 2023
Social determinants of health (SDOH) are conditions in the places where people live, learn, work, and play. These conditions affect a wide range of health and quality of life risks and outcomes. CDC, the World Health Organization (WHO), and others recognize work as a social determinant of health.[1],[2],[3] Despite this recognition, this key SDOH is not fully integrated into public health data collections or assessments.
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
Elrig
FEBRUARY 16, 2023
Get recognized, propel your career: Why you can’t miss ELRIG’s Early Career Professional Impact Award The drug discovery sector consistently delivers innovation and new discoveries that have the potential to transform lives for the better. For that reason, it’s an exceptionally rewarding sector to craft a career in. But while the power and pace of drug discovery relies on a continual influx of bright, enthusiastic minds, it can be a daunting sector for early career professionals (ECPs) to get th
Drug Patent Watch
FEBRUARY 16, 2023
Annual Drug Patent Expirations for LUMAKRAS Lumakras is a drug marketed by Amgen Inc and is included in one NDA. It is available from one supplier. There are three patents… The post New patent for Amgen Inc drug LUMAKRAS appeared first on DrugPatentWatch - Make Better Decisions.
LifeSciVC
FEBRUARY 16, 2023
By Bob Clarke, CEO of Kinaset Therapeutics, as part of the From The Trenches feature of LifeSciVC As I ride the Amtrak towards New York City for a series of meetings on Park Avenue with bankers/analysts, face-to-face (F2F) meetings are back as part of my normal routine. However, the routine certainly has some new facets spawned from our collective experience over the last 3 years.
Molecular Design
FEBRUARY 14, 2023
I’ll be discussing promiscuity in this post and, if there’s one thing that religious leaders and drug discovery scientists agree on, it’s that promiscuity is a Bad Thing. In the drug discovery context compounds that bind to many targets or exhibit ‘activity’ in many assays are described as promiscuous. I first became aware that promiscuity was a practical (as opposed to a moral) problem when we started to use high-throughput screening (HTS) at Zeneca in the mid-1990s and we soon learned that not
Drug & Device Law
FEBRUARY 17, 2023
Today’s case is not about drugs or medical devices. It is about popcorn, a perfect prompt (or as good as ours ever get) for a rant about movies. We are working our way through the Oscar nominees, in anticipation of the upcoming Academy Awards. (Pre-apocalypse, we hosted an annual Oscar party, featuring good food, good wine, and just enough wagering – and cheating – for a bit of hostility.
Drug Patent Watch
FEBRUARY 16, 2023
Annual Drug Patent Expirations for HETLIOZ Hetlioz is a drug marketed by Vanda Pharms Inc and is included in two NDAs. It is available from one supplier. There are twenty-one… The post New patent for Vanda Pharms drug HETLIOZ appeared first on DrugPatentWatch - Make Better Decisions.
Drug Patent Watch
FEBRUARY 15, 2023
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Switzerland. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating… The post Which pharmaceutical companies have the most SPCs in Switzerland? appeared first on DrugPatentWatch - Make Better Decisions.
Drug Patent Watch
FEBRUARY 15, 2023
Annual Drug Patent Expirations for TLANDO Tlando is a drug marketed by Antares Pharma Inc and is included in one NDA. It is available from one supplier. There are eleven… The post New patent for Antares Pharma drug TLANDO appeared first on DrugPatentWatch - Make Better Decisions.
Drug Patent Watch
FEBRUARY 14, 2023
Annual Drug Patent Expirations for LENVIMA Lenvima is a drug marketed by Eisai Inc and is included in one NDA. It is available from one supplier. There are six patents… The post New patent for Eisai Inc drug LENVIMA appeared first on DrugPatentWatch - Make Better Decisions.
Drug Patent Watch
FEBRUARY 14, 2023
Annual Drug Patent Expirations for RYANODEX Ryanodex is a drug marketed by Eagle Pharms and is included in one NDA. It is available from one supplier. There are five patents… The post New patent expiration for Eagle Pharms drug RYANODEX appeared first on DrugPatentWatch - Make Better Decisions.
Expert insights. Personalized for you.
105 
Let's personalize your content